Vimarsana
Biggest News Aggregation in the World

Page 2 - Maples Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Maples Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Maples Group Today - Breaking & Trending Today

Predictions for 2024: Fund services - Vimarsana News

Predictions for 2024: Fund services

Experts from BNY Mellon, MUFG Investor Services, Citco Fund Services, Maples Group, JTC, CSC, Suntera Global, Jersey Finance, PFA Solutions, 4Pines Fund Services and Allvue Systems provide their predictions for the fund services industry. 

Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases - Vimarsana News

Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases

Proposed acquisition will enrich the AstraZeneca cell therapy pipeline with clinical-stage autologous BCMA/CD19 CAR-T therapy targeting haematologic malignancies and autoimmune diseases, and...

Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases - Gracell Biotechnologies (NASDAQ:GRCL) - Vimarsana News

Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases - Gracell Biotechnologies (NASDAQ:GRCL)

Proposed acquisition will enrich the AstraZeneca cell therapy pipeline with clinical-stage autologous BCMA/CD19 CAR-T therapy targeting haematologic malignancies and autoimmune diseases, and proprietary cell therapy

Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across ... - Vimarsana News

Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across ...

Proposed acquisition will enrich the AstraZeneca cell therapy pipeline with clinical-stage autologous BCMA/CD19 CAR-T therapy targeting haematologic malignancies and autoimmune diseases, and proprietary cell therapy manufacturing platform

[Event] Fraud Asset Tracing & Recovery - January 23rd - 24th, Miami, FL | American Conference Institute (ACI) - Vimarsana News

[Event] Fraud Asset Tracing & Recovery - January 23rd - 24th, Miami, FL | American Conference Institute (ACI)

For over fifteen years, the “who’s who” in Asset Recovery and Insolvency from around the globe have made it a point to attend this event – widely regarded as the true destination and...